100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary Chapter 2 Stahl Notes $7.99   Add to cart

Summary

Summary Chapter 2 Stahl Notes

 9 views  0 purchase
  • Course
  • PMHNP
  • Institution
  • PMHNP

Summary of the content in chapter 2 of stahls psychopharmacology, including important figures and tables.

Preview 2 out of 6  pages

  • No
  • Chapter 2
  • November 14, 2024
  • 6
  • 2024/2025
  • Summary
book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:
  • PMHNP
  • PMHNP
avatar-seller
kaitlinhafner
Chapter 2: Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug
Action
o Sites of action for therapeutic agents
o Transporters for neurotransmitters (33%)
o Receptors coupled to G proteins (33%)
o Enzymes (10%)

Nomenclature for Medications
o Moving from traditionally naming medications for their therapeutic indications
 Antidepressant, antipsychotic, etc.
 So called antipsychotics being used for depression shows how
ineffective the current nomenclature is
 Changing to nomenclature based on neuroscience
 Serotonin transport inhibitor
 Dopamine D2 and serotonin 5HT2A antagonist
o Genetic Variation
o Moving towards understanding gene variations and how those impacts whether the
patient responds to the drug or not
 Pharmacogenomics

Neurotransmitter Transporters as Targets of Drug Action
o 12-transmembrane-region proteins
o Utilized by presynaptic reuptake and vesicular storage
o Cross the membrane 12 times
 Plasma Membrane Transporters
 Some are presynaptic and others are on glial membranes
o Solute carrier SLC6 gene family
 Includes transporters for the monoamines:
 Serotonin, norepinephrine, dopamine
 Neurotransmitter GABA
 Amino acid glycine
o Solute carrier SLC1 gene family
 High affinity glutamate transporters

 Intracellular synaptic vesicle transporters
 SLC18 gene family
o Vesicular monoamine transporters (VMATs) for:
 Serotonin, norepinephrine, dopamine and histamine
o Vesicular acetylcholine transporter (VAChT)
 SLC32 gene family
o Vesicular inhibitory amino acid transporters (VIAATs)
 SLC17 gene family
o Vesicular glutamate transporters
 vGluT1-3
SLC6 Gene Family as Targets of Psychotropic Drugs
o Monoamines use unique presynaptic transporters (each different)
o Serotonin: SERT
o Norepinephrine: NET

, o Dopamine: DAT
 They still have affinity for the other receptors
 If other transportable neurotransmitters or drugs are in the area they
can also be transported into the presynaptic neuron
o NET also has high affinity for dopamine transport
o DAT has high affinity for transport of amphetamines as well as
dopamine
o SERT has high affinity for MDMA transport
o Same vesicular transporter in the synaptic vesicle membranes of all three monoamines
plus histamine
o Vesicular monoamine transporter 2: VMAT2
o Energy
o Transporters in the SLC6 gene family couple the “downhill” transport of sodium with
the “uphill” transport of the monoamines
 Up a concentration gradient
 Sodium dependent cotransporters (sodium-potassium ATPase)  sodium
pump
 Usually also involves additional cotransport of chloride
 In some cases, also the counter transport of potassium
o Binding sites
o One site for the monoamine to bind
o Binding sites for 2 sodium ions
 Dimer
 The concept that these transporters may exist as 2 copies working
together with each other
 Monamines are believed to exist as dimers
o SSRIs
o Drug binds to the transporter and inhibits the reuptake of monoamines
 They do NOT bind to the substrate site  they bind to allosteric site
 Substrate site: where the monoamine itself binds to the transporter
o Designed for unipolar depression
 Act at SERT, NET and DAT or some combination of these

o “Antidepressant” is misnomer
o Good for treating GAD, social phobia and other anxiety forms
o They help with neuropathic pain and post herpetic neuralgia
o Can improve eating disorders, OCD, trauma and stress related disorders
o We do NOT use agents that block monoamine transporters in bipolar or mixed
states
SLC6 and SLC1 Gene Family as Targets of Psychotropic Drugs
o GABA
o Transported by the GAT1-4
 GAT1-4 is selectively blocked by the anticonvulsant: Tiagabine
 Increases synaptic GABA concentrations
o  therapeutic actions in anxiety, sleep disorders
 No other inhibitors of this transport system are available for clinical use
o Glycine
o Belong to the SLC6 gene family
 No drugs on the market to block glycine transporters

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller kaitlinhafner. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $7.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67096 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$7.99
  • (0)
  Add to cart